Commentary - EC final report: bark worse than bite?
This article was originally published in Scrip
Executive Summary
On July 8th, 2009, the European Commission reported on its 18-month inquiry into competition in the pharmaceuticals sector. Bill Batchelor of Baker & McKenzie's Brussels antitrust practice describes some of the implications of the much-awaited report.